glatiramer acetate and its Impurities
Glatiramer Acetate used to treat multiple sclerosis. It is an immunomodulator medication. Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability. Reference standards of Glatiramer Acetate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Benzyl (S)-5-(((S)-1-(((S)-3-(4-hydroxyphenyl)-1-(methylamino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-4-((S)-2-(methylamino)-4-(2,2,2-trifluoroacetamido)butanamido)-5-oxopentanoate
Benzyl (S)-5-(((S)-1-(((S)-3-(4-hydroxyphenyl)-1-(methylamino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-4-((S)-2-(methylamino)-4-(2,2,2-trifluoroacetamido)butanamido)-5-oxopentanoate
Catalogue No.:PAI 07 008010
CAS :
NA
Molecular Formula : C32H41F3N6O8
Molecular Weight : 694.71
(S)-5-(((S)-1-(((S)-3-(4-Hydroxyphenyl)-1-(methylamino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-4-((S)-2-(methylamino)-4-(2,2,2-trifluoroacetamido)butanamido)-5-oxopentanoic acid
(S)-5-(((S)-1-(((S)-3-(4-Hydroxyphenyl)-1-(methylamino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-4-((S)-2-(methylamino)-4-(2,2,2-trifluoroacetamido)butanamido)-5-oxopentanoic acid
Catalogue No.:PAI 07 008020
CAS :
NA
Molecular Formula : C25H35F3N6O8
Molecular Weight : 604.58